Molina Healthcare (NYSE:MOH) PT Lowered to $331.00

Molina Healthcare (NYSE:MOH) had its price objective decreased by investment analysts at Robert W. Baird from $405.00 to $331.00 in a report released on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s target price points to a potential upside of 1.67% from the stock’s previous close.

Several other research firms have also recently commented on MOH. Jefferies Financial Group cut their price target on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a report on Wednesday, July 24th. Stephens reissued an “equal weight” rating and set a $320.00 price target on shares of Molina Healthcare in a research report on Thursday, July 25th. Wells Fargo & Company raised their price objective on shares of Molina Healthcare from $315.00 to $360.00 and gave the stock an “equal weight” rating in a research report on Monday, August 5th. StockNews.com upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating in a report on Friday, October 18th. Finally, Truist Financial cut their price target on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating for the company in a report on Monday, July 15th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $367.00.

Molina Healthcare Trading Up 0.6 %

Shares of MOH opened at $325.56 on Thursday. The firm’s fifty day moving average is $335.23 and its two-hundred day moving average is $330.07. The stock has a market cap of $19.08 billion, a PE ratio of 17.84, a price-to-earnings-growth ratio of 0.99 and a beta of 0.58. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.49. Molina Healthcare has a 52-week low of $272.69 and a 52-week high of $423.92.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share for the quarter, topping analysts’ consensus estimates of $5.96 by $0.05. The firm had revenue of $10.34 billion for the quarter, compared to analyst estimates of $9.92 billion. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. Molina Healthcare’s quarterly revenue was up 21.0% on a year-over-year basis. During the same period in the previous year, the business posted $5.05 earnings per share. Research analysts forecast that Molina Healthcare will post 23.5 earnings per share for the current fiscal year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of the company’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now directly owns 9,473 shares in the company, valued at $3,282,583.96. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the completion of the transaction, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at $3,282,583.96. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the sale, the director now directly owns 18,025 shares in the company, valued at $6,114,260.25. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by insiders.

Hedge Funds Weigh In On Molina Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MOH. Quent Capital LLC raised its stake in shares of Molina Healthcare by 6.8% in the first quarter. Quent Capital LLC now owns 489 shares of the company’s stock valued at $201,000 after acquiring an additional 31 shares in the last quarter. Custom Index Systems LLC raised its position in Molina Healthcare by 5.0% in the 2nd quarter. Custom Index Systems LLC now owns 690 shares of the company’s stock valued at $205,000 after purchasing an additional 33 shares in the last quarter. AlphaMark Advisors LLC boosted its stake in shares of Molina Healthcare by 1.1% in the 2nd quarter. AlphaMark Advisors LLC now owns 3,543 shares of the company’s stock valued at $1,053,000 after buying an additional 40 shares during the period. Oliver Luxxe Assets LLC grew its position in shares of Molina Healthcare by 1.3% during the third quarter. Oliver Luxxe Assets LLC now owns 4,428 shares of the company’s stock worth $1,526,000 after buying an additional 55 shares in the last quarter. Finally, Arizona State Retirement System grew its position in shares of Molina Healthcare by 0.4% during the second quarter. Arizona State Retirement System now owns 16,092 shares of the company’s stock worth $4,784,000 after buying an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.